Open access

Introductory Chapter: Artificial Intelligence Will Not Replace Humans – Humans Using Artificial Intelligence Will Replace Those Who Do Not

Written By

Stanislaw P. Stawicki and Thomas R. Wojda

Published: 20 November 2024

DOI: 10.5772/intechopen.115221

Chapter metrics overview

162 Chapter Downloads

View Full Metrics

1. Introduction

We have witnessed an unprecedented technological revolution during the past 3–4 decades [1, 2, 3]. A confluence of highly synergistic factors, including the widespread adoption of the Internet, ongoing advances in microchip technology, the evolution and refinement of “specialty microchips” able to hyper-focus on a specific computational task, blockchain and “internet of things” (IoT), and the growing body of associated theoretical knowledge, all combined to create a perfect environment for the entrance of artificial intelligence (AI) and machine learning (ML) into the mainstream [4, 5, 6, 7, 8]. At this time, the rate of progress is becoming so rapid that our “vantage point” on this remarkable evolutionary process is in itself becoming a “moving target,” where “the way things are today” will not necessarily reflect tomorrow’s reality.

Advertisement

2. The evolving interaction of humans and intelligent machines

As artificial intelligence becomes more than just a “catch phrase” and moves into mainstream applications, human-AI interactions are bound to exponentially increase. In fact, these interactions have the potential to become too intricate and complex for humans to identify when the so-called point of “singularity” is reached, denoting a state of irreversible and ever-increasing “machine dominance” over human intelligence [3, 9, 10]. Concurrently, it is hoped that a substantial amount of new knowledge regarding these previously unexplored interactions can be generated within a reasonably short time frame, effectively facilitating a continuous learning/feedback-loop cycle that will hopefully lead to a much better understanding of the human civilization’s initial “non-human intelligence” encounters [11, 12, 13, 14].

At the same time, as both the use and utility of AI-driven applications continue to increase, important observations and trends emerge. One of the most important trends is the realization that AI can be only as good (e.g., accurate, effective, and useful) as its algorithms and data inputs [15]. Another important observation is that “human-guided AI” maybe more suitable in everyday applications than “autonomous AI,” at least at the current point in time [16]. In addition, it is becoming increasingly apparent that the contemporary set of technological limitations (both related to hardware and software) makes AI-based applications most optimal in the broadly defined area of “productivity enhancement,” where humans equipped with AI assistance can be significantly more productive, with both greater quality and quantity of output [17, 18], and hopefully with an enhanced operator work experience. Within the latter context, autonomous Black Box AI (BBAI), a system whose inputs and operations are not “visible” to the user or other parties, inherently requires human oversight, mainly because of its propensity to “confabulate” output based on nontransparent data processing pathways [19], further strengthening the case for human-guided/supervised AI implementations.

Advertisement

3. Artificial intelligence in healthcare

AI is rapidly transforming healthcare, fundamentally altering how we diagnose, treat, and manage diseases. The convergence of the above-mentioned emerging technologies has created an unprecedented opportunity for AI to enhance healthcare delivery and achieve what is often referred to as the “quadruple aim”: improving patient experience, enhancing population health, reducing costs, and positively transforming the work life of healthcare providers [20, 21].

Currently, AI is being deployed to automate repetitive and time-consuming tasks, particularly in precision diagnostics. For instance, AI algorithms analyze medical images for conditions such as diabetic retinopathy and lung cancer with a level of accuracy that often rivals or exceeds that of human specialists [22], without the associated “human fatigue” and fluctuating performance. These systems not only improve diagnostic accuracy but also significantly reduce the time required for image analysis, thus expediting the overall diagnostic process [23, 24]. Furthermore, AI-powered virtual assistants and large language model (LLM) based “chat bots” maybe used in certain settings to assist patients in managing their symptoms and navigating healthcare systems [25, 26]. These tools, integrated with wearable devices, could provide real-time health monitoring and personalized feedback, enhancing patient engagement and enabling early intervention for various health conditions.

Advertisement

4. The promise of tomorrow

In the future, AI systems will likely evolve to incorporate ambient intelligence, creating a more seamless and intuitive interaction between technology, healthcare professionals, and patients. This will involve the large-scale adoption of precision imaging technologies and the development of AI systems capable of integrating diverse datasets, including electronic health records (EHRs), genomic (and in general other “omics” [27, 28]) information, and real-time patient monitoring data [29, 30, 31]. Such systems will enable more precise and individualized treatment plans, moving us closer to the realization of the promise of precision medicine.

In the field of drug discovery, AI is poised to revolutionize the development of new therapeutics. By analyzing vast amounts of biomedical and known molecular data, AI can identify potential drug targets and predict the efficacy and safety of new compounds more quickly and accurately than traditional methods [32, 33]. This capability is expected to significantly reduce the time and cost associated with bringing new drugs to market, ultimately leading to more effective treatments for a wide range of diseases. It will also supercharge the emerging field of personalized/precision medicine [33, 34].

In the long term, AI has the potential to transform healthcare into a fully integrated, predictive (and thus preventive), and highly personalized system. On can hypothesize that healthcare systems of the future maybe interconnected through a unified digital infrastructure, enabling the continuous monitoring and analysis of patient data [35, 36]. Blockchain may play a prominent role in such a global paradigm [7, 37]. AI-driven predictive analytics will ideally be able to help anticipate health issues before they become critical, allowing for early intervention and more effective management of chronic conditions. Additionally, the development of AI-powered tools such as “digital twins”—virtual replicas of patients—will enable healthcare professionals to simulate and evaluate the impact of different treatment options before exposing patients to any undue risks, thus ensuring the most effective, highly optimized, and truly personalized care [38].

Finally, AI will play a crucial role in addressing some of the most significant challenges facing health systems today, including the shortage of healthcare professionals and the increasing complexity of medical knowledge. By automating routine tasks and augmenting the capabilities of healthcare practitioners, AI will help to alleviate the burden on healthcare facilities and providers, and ensure that high-quality care is accessible to all. In addition, adaptively evolving care guidelines will provide frontline healthcare staff with the most effective and up-to-date information without delays and/or potential “expert consensus” biases [39, 40].

Advertisement

5. Synthesis and conclusion

As artificial intelligence becomes more prevalent and universally accepted, and as it increasingly penetrates into more domains of our lives, it will be critically important to identify, categorize, develop, and optimize various “utility-implementation” pairs applicable to specific use-case scenarios. In the near future, the most likely benefit and use-case for AI-based applications will be the broadly understood “increase in productivity” enjoyed by humans utilizing AI in their private and professional lives. Beyond this immediate period, it is likely that our understanding of AI and its risks, benefits, and alternatives will guide more autonomous applications of this transformational technology across selected functional areas and sectors of our economy. This may include more liberal applications of AI/ML in healthcare, where specific benefits may manifest as greater clinical throughput, increased clinical accuracy and efficacy, whilst significantly increasing provider job satisfaction by reducing administrative burdens and various nonclinical, minimally productive, and/or counterproductive activities (e.g., excessive time spent completing medical records or extended wait times to receive diagnostic results). Any such advancements and implementations will need to be very carefully supervised and closely monitored, with strong provisions and hard stops built into the overall implementation system to ensure continued focus on the quality, safety, and ultimately value of care provided.

References

  1. 1. Schwab K. The Fourth Industrial Revolution. New York, New York: Crown Business; 2017
  2. 2. Freeman C, Louçã F. As Time Goes by: From the Industrial Revolutions to the Information Revolution. Oxford, England: Oxford University Press; 2001
  3. 3. Stawicki SP et al. Introductory chapter: Artificial intelligence in healthcare–where do we go from here? In: Stawicki SP, editor. Artificial Intelligence in Medicine and Surgery-An Exploration of Current Trends, Potential Opportunities, and Evolving Threats. Vol. 1. London, UK: IntechOpen; 2023
  4. 4. Özelli T. Novacene: The emergence of low cost microchip enabled information-economy from inexpensive petroleum based mass-production economy. Journal of Ekonomi. 2019;1(2):155-204
  5. 5. Kühne A. Emerging Trends in Machine Autonomy: Defining and Regulating Intelligent Machines. Available from: https://phaidra.univie.ac.at/detail/o:1312251.pdf
  6. 6. Taulli T, Oni M. Artificial Intelligence Basics. Berkeley, CA: Apress, Springer; 2019
  7. 7. Stawicki S. Blockchain in Healthcare: From Disruption to Integration. Vol. 10. Cham, Switzerland: Springer Nature; 2023
  8. 8. Stawicki SP. Novel Cryptocurrency Investment Approaches: Risk Reduction and Diversification through Index Based Strategies. London, England: IntechOpen; 2024
  9. 9. Gilder G. Life after Google: The Fall of Big Data and the Rise of the Blockchain Economy. New York, NY: Simon and Schuster; 2018
  10. 10. Chace C. Artificial Intelligence and the Two Singularities. New York, NY, USA: Chapman and Hall/CRC; 2018
  11. 11. Miletić T. Human-Artificial Intelligence Symbiosis: The Possibility of Moral Augmentation. University of Rijeka, Faculty of Humanities and Social Sciences, Department; 2021. Available from: https://www.unirepository.svkri.uniri.hr/islandora/object/ffri:3024/datastream/PDF/download
  12. 12. Stavrou I, Katsiampoura G, Skordoulis C. “Extraterrestrial Intelligence”-Science Fiction Literature in Science Education: A Case Study. XIV IOSTE. p. 1060
  13. 13. Kowert W. The foreseeability of human-artificial intelligence interactions. Texas Law Review. 2017;96:181
  14. 14. Miller A. The intrinsically linked future for human and artificial intelligence interaction. Journal of Big Data. 2019;6(1):1-9
  15. 15. Lu Y. Artificial intelligence: A survey on evolution, models, applications and future trends. Journal of Management Analytics. 2019;6(1):1-29
  16. 16. Cox LA Jr. Causally explainable decision recommendations using causal artificial intelligence. In: AI-ML for Decision and Risk Analysis: Challenges and Opportunities for Normative Decision Theory. Cham, Switzerland: Springer; 2023. pp. 273-316
  17. 17. Al Naqbi H, Bahroun Z, Ahmed V. Enhancing work productivity through generative artificial intelligence: A comprehensive literature review. Sustainability. 2024;16(3):1166
  18. 18. Ji Y. Artificial Intelligence, Productivity and Performance. University of Warwick; 2023. Available from: https://wrap.warwick.ac.uk/182768/1/WRAP_Theses_Ji_2023.pdf
  19. 19. Scatiggio V. Tackling the Issue of Bias in Artificial Intelligence to Design AI-Driven Fair and Inclusive Service Systems. How Human Biases Are Breaching into AI Algorithms, with Severe Impacts on Individuals and Societies, and What Designers Can Do to Face this Phenomenon and Change for the Better. 2020. Available from: https://www.politesi.polimi.it/bitstream/10589/186118/3/Master%20Thesis%20PSSD_%20Vittoria%20Scatiggio.pdf
  20. 20. Olayiwola JN, Rastetter M. Aiming for health equity: The Bullseye of the quadruple aim. Journal of Hospital Management and Health Policy. 2021;5:1-6
  21. 21. Flanagan N. The quadruple aim: Improving working conditions for health care providers. Caring for the Ages. 2018;19(1):11
  22. 22. Esteva A et al. A guide to deep learning in healthcare. Nature Medicine. 2019;25(1):24-29
  23. 23. Castaneda C et al. Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine. Journal of Clinical Bioinformatics. 2015;5:1-16
  24. 24. Xue Y et al. Accuracy of ultrasound diagnosis of thyroid nodules based on artificial intelligence-assisted diagnostic technology: A systematic review and meta-analysis. International Journal of Endocrinology. 2022;2022(1):9492056
  25. 25. De Choudhury M, Pendse SR, Kumar N. Benefits and harms of large language models in digital mental health. arXiv preprint arXiv:2311.14693. 2023:1-27
  26. 26. Cai P. Generative Language Models for Personalized Information Understanding. 2024. Available from: https://scholarworks.umass.edu/cgi/viewcontent.cgi?article=4123&context=dissertations_2
  27. 27. Koromina M, Pandi M-T, Patrinos GP. Rethinking drug repositioning and development with artificial intelligence, machine learning, and omics. OMICS: A Journal of Integrative Biology. 2019;23(11):539-548
  28. 28. Gao F, Huang K, Xing Y. Artificial Intelligence in Omics. Oxford, England: Oxford University Press; 2022. pp. 811-813
  29. 29. Bajwa J et al. Artificial intelligence in healthcare: Transforming the practice of medicine. Future Healthcare Journal. 2021;8(2):e188
  30. 30. Stawicki SP. Application of financial analysis techniques to vital sign data: A novel method of trend interpretation in the intensive care unit. OPUS. 2007;12:14-16
  31. 31. Stawicki SP et al. Dynamic behavior of venous collapsibility and central venous pressure during standardized crystalloid bolus: A prospective, observational, pilot study. International Journal of Critical Illness and Injury Science. 2015;5(2):80-84
  32. 32. Senior AW et al. Improved protein structure prediction using potentials from deep learning. Nature. 2020;577(7792):706-710
  33. 33. Nayarisseri A et al. Artificial intelligence, big data and machine learning approaches in precision medicine & drug discovery. Current Drug Targets. 2021;22(6):631-655
  34. 34. Raparthi M. AI assisted drug discovery: Emphasizing its role in accelerating precision medicine initiatives and improving treatment outcomes. Human-Computer Interaction Perspectives. 2022;2(2):1-10
  35. 35. Benis A et al. One digital health: A unified framework for future health ecosystems. Journal of Medical Internet Research. 2021;23(2):e22189
  36. 36. Kelly JT et al. The internet of things: Impact and implications for health care delivery. Journal of Medical Internet Research. 2020;22(11):e20135
  37. 37. Stawicki SP, Firstenberg MS, Papadimos TJ. What’s new in academic medicine? Blockchain technology in health-care: Bigger, better, fairer, faster, and leaner. International Journal of Academic Medicine. 2018;4:1-11
  38. 38. Kaul R et al. The role of AI for developing digital twins in healthcare: The case of cancer care. Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery. 2023;13(1):e1480
  39. 39. Domínguez J et al. ROAD2H: Development and evaluation of an open-source explainable artificial intelligence approach for managing co-morbidity and clinical guidelines. Learning Health Systems. 2024;8(2):e10391
  40. 40. Johnson WG. Flexible regulation for dynamic products? The case of applying principles-based regulation to medical products using artificial intelligence. Law, Innovation and Technology. 2022;14(2):205-236

Written By

Stanislaw P. Stawicki and Thomas R. Wojda

Published: 20 November 2024